|
|
Study on the prognosis of stroke patients with different risk factors based on lipotomic method |
LIU Jianping GAO Hui▲ ZHANG Lianhong |
Department of Neurology,Jiujiang First People's Hospital,Jiangxi Province,Jiujiang 332000,China |
|
|
Abstract Objective To investigate the prognostic of stroke patients with different risk factors based on lipotomic method.Methods The clinical data of 120 patients with acute ischemic stroke(AIS)admitted to Jiujiang First People's Hospital from February 2021 to February 2023 were retrospectively analyzed,after 3 months of treatment,the patients were divided into good group(n=82)and bad group(n=38)according to prognosis.The effects of age,gender,smoking history,drinking history,hypertension,hyperlipidemia,diabetes,family history of stroke,total cholesterol (TC),triglyceride (TG),glycated hemoglobin(HbA1c)and low-density lipoprotein cholesterol(LDL-C)levels on the poor prognosis of AIS patients were analyzed.Results Among all 120 AIS patients included in the study,38 patients had poor prognosis,with an incidence of 31.67%,and 82 patients had good prognosis,with an incidence of 68.33%.The results of univariate analysis showed that there were no significant differences in gender,smoking history,drinking history,hypertension,hyperlipidemia,diabetes and family genetic history of stroke between the two groups(P>0.05).There were significant differences in age,TC,TG,HbA1c and LDL-C between the two groups(P<0.05).Multiple factors analysis results suggest that age(β=0.266,OR=1.304,95%CI=1.136-1.498),HbA1c (β=0.838,OR=2.312,95%CI=1.269-4.212),LDL-C (β=1.662,OR=5.269,95%CI=2.178-12.745) were risk factors for poor prognosis in AIS patients,and the differences were statistically significant (P<0.05).Conclusion Age,HbA1c and LDL-C are risk factors for poor prognosis of AIS patients.Targeted interventions can be carried out according to the above factors to reduce the incidence of poor prognosis in AIS patients.
|
|
|
|
|
[1] |
王陇德,彭斌,张鸿祺,等.《中国脑卒中防治报告2020》概要[J].中国脑血管病杂志,2022,19(2):136-144.
|
[2] |
李鑫静,张振香,翟清华,等.脑卒中患者照顾者心理健康素养潜在类别分析[J].军事护理,2023,40(4):48-51.
|
[3] |
李利东,潘杰.岭南头皮针结合认知训练治疗脑卒中后轻度认知功能障碍的临床效果[J].中国老年学杂志,2023,43(9):2073-2076.
|
[4] |
冉世前,朱云芬,王杰,等.基于脂质组学揭示饲喂裂殖藻粉对山羊乳脂质的影响[J].食品科学,2023,44(6):227-234.
|
[5] |
沈旭,邹思力,曲乐丰.便携式三维超声在中老年人颈动脉斑块筛查的应用和斑块形成的危险因素分析[J].中国血管外科杂志(电子版),2020,12(3):212-216.
|
[6] |
宋亚君,王翔,陈武.益气开窍汤联合rt-PA 对缺血性脑卒中患者血脂及同型半胱氨酸水平的影响[J].湖北中医药大学学报,2023,25(2):20-22.
|
[7] |
王秀玲,汪轩,王梦迪,等.改良MRI-DRAGON 评分在急性缺血性卒中血管内治疗后预后预测中的价值[J].磁共振成像,2023,14(3):134-139.
|
[8] |
中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组,彭斌,等.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-682.
|
[9] |
谭丽梅,兰希发,祖艳颖.基于改良Rankin 量表评分分析青年缺血性脑卒中患者预后不良的相关影响因素[J].中国临床医生杂志,2023,51(10):1164-1166.
|
[10] |
徐佳辉,江婷婷,王士玉,等.天津市大气污染物对脑卒中发病影响的时间序列分析[J].中国慢性病预防与控制,2023,31(3):188-193.
|
[11] |
解欣然,张蕾,李雪,等.基于LC-MS 分析凉血解毒利湿方对咪喹莫特诱导ApoE-/-小鼠的血清脂质组学的影响[J].时珍国医国药,2023,34(2):260-264.
|
[12] |
张英丰,韦园诗,黄星星,等.基于UPLC-Q-TOF-MS 技术的丹参川芎干预缺血性脑卒中的脑脂质组学研究[J].中国中药杂志,2019,44(20):4511-4518.
|
[13] |
杨静,裴斐菲,赛米热·沙塔尔.白细胞介素-2 和对氧磷脂酶-1 评估急性脑卒中患者阿替普酶静脉溶栓后短期预后的价值[J].中华实用诊断与治疗杂志,2023,37(3):294-299.
|
[14] |
黄绿野.缺血性脑卒中合并房颤及冠心病患者预后的影响因素[J].中国卫生工程学,2023,22(1):54-56,59.
|
[15] |
王建宇,高倩,王勇朝,等.阿替普酶治疗急性缺血性脑卒中患者预后的影响因素[J].河北医药,2022,44(7):1056-1059.
|
[16] |
顾亮亮,王建锋,乔鑫,等.急性缺血性脑卒中患者静脉溶栓前后SCUBE1 水平的变化及其与预后不良的相关性分析[J].卒中与神经疾病,2023,30(3):265-268,277.
|
[17] |
张晓东,武悦,刘亚运.缺血性脑卒中患者外周静脉溶栓后预后影响因素的探索[J/OL].中国动脉硬化杂志:1-13[2024-04-19].http://kns.cnki.net/kcms/detail/43.1262.R.20230920.2253.009.html.
|
[18] |
黄俊仪,张云峰,葛颖超.老年颅内大血管闭塞所致急性缺血性脑卒中患者血栓抽吸治疗近期预后[J].中国老年学杂志,2023,43(21):5139-5143.
|
[19] |
张楠,贾永花,冀旗玲,等.同型半胱氨酸糖化血红蛋白神经胶质纤维酸性蛋白在急性缺血性卒患者中的表达及意义[J].河北医学,2018,24(8):1261-1266.
|
[20] |
徐卫平,张国英,蔡峰,等.南京地区糖尿病足与血清UA、Hcy、HbA1c 和LDL-c 水平相关性研究[J].公共卫生与预防医学,2022,33(5):69-72.
|
[21] |
李萍.血清HbA1c 水平对缺血性脑卒中患者早期神经功能损伤及预后的影响[J].中国卫生工程学,2020,19(4):634-636.
|
[22] |
邓朝苹,李丽,代源,等.大面积急性缺血性脑卒中患者血管内治疗短中期预后的影响因素[J].中华老年心脑血管病杂志,2023,25(2):167-170.
|
[23] |
芦慧,骆燕芳,陆建芳,等.老年急性脑卒中后吞咽功能障碍预后的危险因素分析[J].循证护理,2020,6(11):1210-1213.
|
[24] |
任莎莎,武燕,杨露.血尿酸、低密度脂蛋白胆固醇与急性缺血性脑卒中患者出院结局的关系[J].海南医学,2022,33(13):1642-1645.
|
[25] |
Au A.Metabolomics and Lipidomics of Ischemic Stroke[J].Adv Clin Chem,2018,85:31-69.
|
|
|
|